Monoclonal antibody (mAb): Originally, mAbs were antibodies produced from a single B lymphocyte. Genetic manipulation now allows genes from multiple sources of B lymphocytes (e.g., mouse and human ...

Sanofi and Regeneron's fully human monoclonal antibody Dupixent (dupilumab) has gained approval from the US Food and Drug ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The FDA is shifting away from animal testing in the development of monoclonal antibody therapies and other drugs.

This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

Nasal anti-CD3 mAb ameliorates traumatic brain injury March 26, 2025 In a study published in Nature Neuroscience , researchers from Tiziana Life Sciences Ltd. and collaborators investigated the ...

The randomized, double-blind, placebo-controlled trial aims to assess the safety, tolerability, and efficacy of intranasal foralumab in patients with na-SPMS, a form of multiple sclerosis (MS) ...